Want to see CH:SKAN full AI Analyst Report?
SKAN Stock Chart & Stats
CHF65.70
CHF1.00(1.75%)
At close: 4:00 PM EDT
CHF65.70
CHF1.00(1.75%)
Day’s Range― - ―
52-Week RangeCHF35.75 - CHF73.90
Previous CloseN/A
Volume14.18K
Average Volume (3M)44.87K
Market Cap
CHF1.64B
Enterprise ValueCHF1.30B
Total Cash (Recent Filing)CHF88.47M
Total Debt (Recent Filing)CHF130.63M
Price to Earnings (P/E)54.6
Beta1.02
Next Earnings
Mar 23, 2027EPS Estimate
1.33Next Dividend Ex-DateN/A
Dividend Yield0.3%
Share Statistics
EPS (TTM)1.33
Shares Outstanding22,483,524
10 Day Avg. Volume33,713
30 Day Avg. Volume44,866
Financial Highlights & Ratios
PEG Ratio-1.26
Price to Book (P/B)10.37
Price to Sales (P/S)3.56
P/FCF Ratio56.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.38
Revenue Forecast (FY)CHF395.52M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthThe sharp 2025 revenue rebound reinforces SKAN’s exposure to ongoing pharmaceutical manufacturing investment and demand for aseptic production systems. Sustained top-line expansion can support scale benefits, broaden the installed base, and create additional opportunities for lifecycle services and upgrades.
High Gross MarginsConsistently high gross margins indicate that SKAN’s engineered solutions and specialized contamination-control expertise retain meaningful economic value. This margin structure provides capacity to fund research, service capabilities, and customer support while supporting resilience across project cycles.
Improved Cash GenerationThe return to positive free cash flow after negative results in 2023–2024 improves SKAN’s ability to finance operations, service its installed base, and invest without relying entirely on external capital. Stronger operating cash generation also provides greater flexibility through changing project conditions.
Bears Say
Sharp Leverage IncreaseThe step-up in debt materially reduces financial flexibility compared with SKAN’s previously lightly leveraged position. Higher leverage increases the consequences of any sustained earnings pressure, raises financing sensitivity, and may constrain investment or shareholder distributions while debt remains elevated.
Profitability DeteriorationThe substantial decline in operating and net margins shows that strong revenue growth is not currently translating proportionately into earnings. If margins remain below prior levels, SKAN could have less capacity to absorb project execution costs, fund growth, and generate attractive returns from expansion.
Volatile Free Cash Flow ConversionAlthough free cash flow improved in 2025, its historical volatility and limited conversion of reported earnings indicate that accounting profitability does not consistently become deployable cash. This can make investment planning less predictable and reduce flexibility when leverage and funding needs are higher.
SKAN Group AG News
SKAN FAQ
What was SKAN Group AG’s price range in the past 12 months?
SKAN Group AG lowest stock price was CHF35.75 and its highest was CHF73.90 in the past 12 months.
What is SKAN Group AG’s market cap?
SKAN Group AG’s market cap is CHF1.64B.
When is SKAN Group AG’s upcoming earnings report date?
SKAN Group AG’s upcoming earnings report date is Mar 23, 2027 which is in 152 days.
How were SKAN Group AG’s earnings last quarter?
SKAN Group AG released its earnings results on Aug 18, 2026. The company reported CHF0.214 earnings per share for the quarter.
Is SKAN Group AG overvalued?
According to Wall Street analysts SKAN Group AG’s price is currently Overvalued.
Does SKAN Group AG pay dividends?
SKAN Group AG pays a Annually dividend of CHF0.22 which represents an annual dividend yield of 0.3%. See more information on SKAN Group AG dividends here
What is SKAN Group AG’s EPS estimate?
SKAN Group AG’s EPS estimate is 1.33.
How many shares outstanding does SKAN Group AG have?
SKAN Group AG has 22,483,524 shares outstanding.
What happened to SKAN Group AG’s price movement after its last earnings report?
SKAN Group AG reported an EPS of CHF0.214 in its last earnings report. Following the earnings report the stock price went up 2.253%.
Which hedge fund is a major shareholder of SKAN Group AG?
Currently, no hedge funds are holding shares in CH:SKAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SKAN Group AG
SKAN Group AG is a global leader specializing in critical solutions for the pharmaceutical and chemical sectors, offering advanced isolators, cleanroom technologies, and decontamination processes across Asia, Europe, and the Americas. The company operates through two distinct divisions: Equipment and Solutions (E&S), and Services and Consumables (S&C). Its E&S segment delivers essential products for pharmaceutical manufacturing, including high-tech isolators, integrated automated systems, aseptic filling solutions, and specialized laboratory and cleanroom equipment. Meanwhile, the S&C segment focuses on providing comprehensive life cycle support, ready-to-use consumables, and custom digital and client-specific solutions. Founded in 1968, the company, which changed its name from BV Holding AG to SKAN Group AG in October 2021, is headquartered in Allschwil, Switzerland.